ArticleThe Lancet. Respiratory medicine2020
The time to do serosurveys for COVID-19 is now.
Article in The Lancet. Respiratory medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Trial
- High immunity and low mortality after Omicron and mass event in Cameroon despite low vaccination.Journal of public health in Africa · 2024Article
- Serological prevalence of SARS-CoV-2 antibody among children and young age group (between 2 and 17 years) in India: An interim result from a large multicentric population-based seroepidemiological study.Journal of family medicine and primary care · 2022Article
- Article
- Seroprevalence of SARS-CoV-2 antibodies in Bali Province: Indonesia shows underdetection of COVID-19 cases by routine surveillance.PLOS global public health · 2022Article
- Article
- From first to second wave: follow-up of the prospective COVID-19 cohort (KoCo19) in Munich (Germany).BMC infectious diseases · 2021Article
- SARS-CoV-2 Cumulative Incidence and Period Seroprevalence: Results From a Statewide Population-Based Serosurvey in California.Open forum infectious diseases · 2021Article
- Seroprevalence and risk factors of exposure to COVID-19 in homeless people in Paris, France: a cross-sectional study.The Lancet. Public health · 2021Article
- Seroprevalence of SARS-CoV-2 Infection in the Colombo Municipality Region, Sri Lanka.Frontiers in public health · 2021Article
- The time to act is now: pseudo-systematic review.BMJ (Clinical research ed.) · 2020Review
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.